Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Bempedoic Acid/Ezetimibe Combo

Showing 1-9 of about 9 articles.

Esperion Therapeutics, Inc.

Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference

about 105 days ago

Esperion Therapeutics, Inc.

Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors

about 125 days ago

Esperion Therapeutics, Inc.

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

about 138 days ago

Esperion Therapeutics, Inc.

Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference

about 160 days ago

Esperion Therapeutics, Inc.

Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results

about 162 days ago

Esperion Therapeutics, Inc.

Esperion Announces Initiation of Pivotal Phase 3 Study for the Bempedoic Acid / Ezetimibe Combination Pill

about 163 days ago

Esperion Therapeutics, Inc.

Esperion to Host Analyst and Investor Day Event on October 17

about 190 days ago

Esperion Therapeutics, Inc.

Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2017 Financial Results

about 253 days ago

Esperion Therapeutics, Inc.

Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

about 254 days ago photo-release

Showing 1-9 of about 9 articles.

© 2018 GlobeNewswire, Inc. All Rights Reserved.